Anthony Zulli Pages 2704 - 2708 ( 5 )
Cardiovascular disease (CVD) remains a major cause of death and disability worldwide, thus preventing and inhibiting CVD remains a health priority. Several lines of pharmacological interventions have not met with great success, thus inhibition of novel cellular stress pathways could be a novel therapeutic avenue to treat CVD. This review will focus on homocysteine and endoplasmic reticulum stress linked to mitochondria function, and possible therapeutic avenues for treatment.
Endoplasmic reticulum stress, endothelial function, homocysteine, atherosclerosis, taurine, Nox.
College of Health and Biomedicine, Victoria University, St. Albans, Autstralia.